AlphAIAlphAI — Financial news for AI agents
investing.com$NGVT

Ingevity earnings beat by $0.07, revenue topped estimates

Ingevity (NGVT) reported Q3 EPS of $1.63, beating estimates by $0.07, with revenue at $305.1M, slightly above expectations. The company provided FY 2026 guidance, forecasting EPS of $5.25-$5.45 and revenue of $1.10B. NGVT's stock is down 5.26% over the last 3 months but up 35.38% year-over-year.

Original reporting
investing.com
Published Nov 4, 2026, 10:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 10:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$NGVT
Bullish
high confidence
Mentioned
$NGVT
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NGVTBullishMed
01

Why it matters

The earnings beat and higher EPS guidance are likely to generate buying interest, though revenue guidance remains near consensus.

02

Market read

First‑report earnings data for a US‑listed mid‑cap; relevant for short‑term traders and sector analysts.

03

What to watch

Revenue guidance is slightly below consensus, which could temper enthusiasm.

Relevance 7/10Novelty 7/10Timing: after-hours

Background

Ingevity (NYSE: NGVT) is a specialty chemicals producer. The article provides its Q3 earnings and FY2026 guidance.

Company-level read

Ticker impact

$NGVTBullishHigh confidence
Context

Ingevity reported Q3 EPS of $1.63, beating the $1.56 estimate and set FY2026 EPS guidance of $5.25‑$5.45 above consensus.

Expected impact

potential upside as investors price in the beat and higher guidance

Evidence & confidence

The beat and raised EPS outlook are fresh data that typically drive short‑term buying pressure.

Market effects

Sector

May boost sentiment in the specialty chemicals and industrial chemicals sector.

Regional

United States

Global

Limited to investors tracking US mid‑cap earnings.

Counterpoint

What could challenge this read

The beat could already be priced in, limiting upside.

Key entities

  • Company
    Ingevity

    Specialty chemicals manufacturer reporting Q3 results.

Read at source← All news

StoryIngevity posts Q3 2026 results with lower sales but higher profit and raises full‑year outlook

Also covered by

3 outlets

Related articles

$NGVTMed

Ingevity (NGVT) Lifted EPS Guidance, Is The Stock Still Cheap?

Ingevity (NGVT) raised its full-year EPS guidance despite lower Q3 sales. The stock has fallen 15.34% in the past week but remains up 25.15% over one year. Analysts estimate fair value at $89, suggesting a 30% undervaluation, though its P/E ratio is higher than industry averages. The company plans $300M in share buybacks by 2027.

finance.yahoo.com
$NGVTHighAI 8/10

Ingevity Q3 Earnings Call Highlights

Ingevity (NGVT) reports Q3 earnings, highlighting growth in hybrid vehicle and filtration markets. CEO Dave Li notes benefits from the hybrid transition and new water treatment contracts. Pavement Technologies sales fell 24% due to divestiture and higher asphalt costs. Advanced Polymer Technologies sales rose 18%. The company narrowed its 2026 adjusted EBITDA outlook to $385M-$395M and expects $1.1B in sales. Ingevity repurchased $39M in shares during Q3.

finance.yahoo.com
$NGVTMed

Ingevity (NGVT) Q3 2026 Earnings Call Transcript

Ingevity (NGVT) reported Q3 2026 sales of $305M, down 8% YoY due to divestitures, but up 2% excluding them. Adjusted EBITDA was $108M, down 2%, with margins expanding to 35.4%. EPS rose 24% to $1.63. The company highlighted growth in filtration and water treatment, secured new contracts, and repurchased $39M in shares. Full-year adjusted EBITDA is expected to be $385M-$395M, with sales around $1.1B and EPS of $5.25-$5.45.

finance.yahoo.com
$NGVTMed

Ingevity reports third quarter 2026 financial results

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports third quarter 2026 financial results Third Quarter 2026 Results and Recent Highlights: • Net sales of $305.1 million decreased 8% from prior year; exclu

SEC EDGAR 8-K
$NGVTHigh

Ingevity reports third quarter 2026 financial results

Ingevity reported Q3 2026 net sales of $305.1M, down 8% YoY. Net income rose to $51.1M per diluted share. Adjusted EBITDA fell $108M but margin expanded to 35.4%. The company narrowed its full-year adjusted EBITDA outlook to $385M-$395M. CEO Dave Li cited strong Performance Materials but noted challenges in Pavement Technologies. Ingevity (NYSE: NGVT) plans to host an earnings call on November 5, 2026.

stocktitan.net